US Bancorp’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-28
Closed -$180 4170
2026
Q1
$180 Buy
+28
New +$216 ﹤0.01% 4109
2025
Q3
Sell
-4,460
Closed -$23.3K 4021
2025
Q2
$23.3K Sell
4,460
-440
-9% -$2.24K ﹤0.01% 3112
2025
Q1
$26.6K Buy
4,900
+100
+2% +$472 ﹤0.01% 3051
2024
Q4
$21.9K Buy
4,800
+1,400
+41% +$7.17K ﹤0.01% 3112
2024
Q3
$17.7K Buy
+3,400
New +$15.4K ﹤0.01% 3166

Other funds holding AVAH

US Bancorp's AVAH Position: Q2 2026 in Review

US Bancorp sold out of Aveanna Healthcare (AVAH) in Q2 2026, closing a stake of 28 shares — an estimated $180 sold.

US Bancorp first reported a position in AVAH in Q3 2024 and held it in 5 quarters. The position peaked at $26.6K in Q1 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • US Bancorp reported no remaining Aveanna Healthcare position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 28 Aveanna Healthcare shares in Q2 2026, an estimated $180.
  • US Bancorp first reported a position in Aveanna Healthcare in Q3 2024 and held it in 5 quarters.
  • US Bancorp's Aveanna Healthcare position peaked at $26.6K in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.